Skip to content
Disclosery

Form 4 filed by Chimovits Erez

Chimovits Erez filed this Form 4 on ADARx Pharmaceuticals, Inc. with 9 transaction rows and 0 holding rows, accepted by EDGAR 2026-09-30 21:29:36 UTC.

Accession
0000947871-26-000912
Filer
CIK 1706399
Filed
2026-09-30
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Issuer and reporting owners

Issuer: ADARx Pharmaceuticals, Inc. (CIK 1802369)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-09-28C converted+7,127,0197,127,019I See footnotes
Common Stock 2026-09-28C converted+1,333,9758,460,994I See footnotes
Common Stock 2026-09-28C converted+513,0678,974,061I See footnotes
Common Stock 2026-09-28C converted+256,4489,230,509I See footnotes
Common Stock 2026-09-28P bought+61,516$179,292,025I See footnotes
Series A Preferred Stock derivative2026-09-28C converted-7,127,019$00I See footnotes
Series B Preferred Stock derivative2026-09-28C converted-1,333,975$00I See footnotes
Series B-1 Preferred Stock derivative2026-09-28C converted-513,067$00I See footnotes
Series C Preferred Stock derivative2026-09-28C converted-256,448$00I See footnotes